Furthermore, since FOLR regulates the PI3K pathway through INSR, and acts as a bridge between tumor metabolic reprogramming and EMT, dual targeting of FOLR and INSR can monitor the occurrence, metastasis and prognosis of CRC with greater accuracy. This evidence concerns the gene PIK3CA and colorectal carcinoma.